China Health Group Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Ho Chung
Chief executive officer
HK$1.7m
Total compensation
| CEO salary percentage | 98.93% |
| CEO tenure | 8.1yrs |
| CEO ownership | n/a |
| Management average tenure | 7.1yrs |
| Board average tenure | less than a year |
Recent management updates
Recent updates
Here's Why China Health Group Limited's (HKG:673) CEO Compensation Is The Least Of Shareholders' Concerns
Sep 05
Shareholders Will Probably Not Have Any Issues With China Health Group Limited's (HKG:673) CEO Compensation
Sep 11We Think China Health Group (HKG:673) Has A Fair Chunk Of Debt
Dec 01We Discuss Why China Health Group Limited's (HKG:673) CEO May Deserve A Higher Pay Packet
Sep 23We Think Some Shareholders May Hesitate To Increase China Health Group Limited's (HKG:673) CEO Compensation
Sep 02Did China Health Group Limited (HKG:673) Insiders Sell Shares?
Feb 16
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2025 | n/a | n/a | -HK$61m |
| Jun 30 2025 | n/a | n/a | -HK$64m |
| Mar 31 2025 | HK$2m | HK$2m | -HK$68m |
| Dec 31 2024 | n/a | n/a | -HK$55m |
| Sep 30 2024 | n/a | n/a | -HK$43m |
| Jun 30 2024 | n/a | n/a | -HK$41m |
| Mar 31 2024 | HK$1m | HK$1m | -HK$40m |
| Dec 31 2023 | n/a | n/a | -HK$35m |
| Sep 30 2023 | n/a | n/a | -HK$29m |
| Jun 30 2023 | n/a | n/a | -HK$36m |
| Mar 31 2023 | HK$1m | HK$1m | -HK$42m |
| Dec 31 2022 | n/a | n/a | -HK$38m |
| Sep 30 2022 | n/a | n/a | -HK$35m |
| Jun 30 2022 | n/a | n/a | -HK$23m |
| Mar 31 2022 | HK$2m | HK$1m | -HK$12m |
| Dec 31 2021 | n/a | n/a | -HK$11m |
| Sep 30 2021 | n/a | n/a | -HK$9m |
| Jun 30 2021 | n/a | n/a | -HK$8m |
| Mar 31 2021 | HK$2m | HK$1m | -HK$8m |
| Dec 31 2020 | n/a | n/a | -HK$23m |
| Sep 30 2020 | n/a | n/a | -HK$38m |
| Jun 30 2020 | n/a | n/a | -HK$37m |
| Mar 31 2020 | HK$2m | HK$1m | -HK$37m |
| Dec 31 2019 | n/a | n/a | -HK$29m |
| Sep 30 2019 | n/a | n/a | -HK$22m |
| Jun 30 2019 | n/a | n/a | -HK$22m |
| Mar 31 2019 | HK$2m | HK$2m | -HK$23m |
Compensation vs Market: Ho's total compensation ($USD215.40K) is about average for companies of similar size in the Hong Kong market ($USD237.22K).
Compensation vs Earnings: Ho's compensation has increased whilst the company is unprofitable.
CEO
Ho Chung (62 yo)
Mr. Ho Chung has been an Executive Director at China Health Group Limited since December 28, 2012 and has been its Chief Executive Officer since December 11, 2017. Mr. Chung has an experience in investment...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 8.1yrs | HK$1.68m | no data | |
| Chairman of the Board | less than a year | no data | no data | |
| Chief Financial Officer | 7.8yrs | no data | no data | |
| Chief Operating Officer and Vice President | no data | no data | no data | |
| Executive Director | less than a year | no data | 7.47% HK$ 78.0m | |
| Company Secretary | 16.8yrs | no data | no data | |
| Senior Consultant | 6.3yrs | HK$130.00k | no data |
Experienced Management: 673's management team is seasoned and experienced (7.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Executive Director | 13.1yrs | HK$1.68m | no data | |
| Chairman of the Board | less than a year | no data | no data | |
| Executive Director | less than a year | no data | 7.47% HK$ 78.0m | |
| Non-Executive Director | less than a year | HK$8.00k | 38.91% HK$ 406.4m | |
| Independent Non-Executive Director | 1.1yrs | HK$25.00k | no data | |
| Non-Executive Director | 8.5yrs | HK$100.00k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | less than a year | no data | no data |
Experienced Board: 673's board of directors are not considered experienced ( 0.3 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/01/16 09:59 |
| End of Day Share Price | 2026/01/16 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
China Health Group Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.